MXPA03005044A - Sistema gelificante reversible para administracion ocular de farmacos. - Google Patents

Sistema gelificante reversible para administracion ocular de farmacos.

Info

Publication number
MXPA03005044A
MXPA03005044A MXPA03005044A MXPA03005044A MXPA03005044A MX PA03005044 A MXPA03005044 A MX PA03005044A MX PA03005044 A MXPA03005044 A MX PA03005044A MX PA03005044 A MXPA03005044 A MX PA03005044A MX PA03005044 A MXPA03005044 A MX PA03005044A
Authority
MX
Mexico
Prior art keywords
drug delivery
gelling system
ocular drug
reversible gelling
reversible
Prior art date
Application number
MXPA03005044A
Other languages
English (en)
Inventor
Erning Xia
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MXPA03005044A publication Critical patent/MXPA03005044A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
MXPA03005044A 2000-12-06 2001-12-03 Sistema gelificante reversible para administracion ocular de farmacos. MXPA03005044A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/731,290 US6703039B2 (en) 2000-12-06 2000-12-06 Reversible gelling system for ocular drug delivery
PCT/US2001/046498 WO2002045683A2 (en) 2000-12-06 2001-12-03 Reversible gelling system for ocular drug delivery

Publications (1)

Publication Number Publication Date
MXPA03005044A true MXPA03005044A (es) 2003-09-05

Family

ID=24938883

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005044A MXPA03005044A (es) 2000-12-06 2001-12-03 Sistema gelificante reversible para administracion ocular de farmacos.

Country Status (13)

Country Link
US (1) US6703039B2 (es)
EP (1) EP1339386B1 (es)
JP (1) JP2004514731A (es)
KR (1) KR100840438B1 (es)
CN (1) CN100350976C (es)
AU (2) AU2002233978B2 (es)
BR (1) BR0116186A (es)
CA (1) CA2430995C (es)
DE (1) DE60126321T2 (es)
ES (1) ES2278799T3 (es)
HK (1) HK1059728A1 (es)
MX (1) MXPA03005044A (es)
WO (1) WO2002045683A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914815B2 (en) * 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US8697109B2 (en) * 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US7935332B2 (en) 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
US8647612B2 (en) * 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
KR100912307B1 (ko) * 2004-10-21 2009-08-14 유니버시티 오브 아이오와 리써치 파운데이션 동일계내 제어된 방출 약물 전달 시스템
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
EP1848749B1 (en) 2005-02-04 2018-10-31 Auburn University Contact drug delivery system
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
WO2008060575A2 (en) 2006-11-13 2008-05-22 Auburn University Drug delivery system and method
WO2008067403A2 (en) * 2006-11-28 2008-06-05 Encore Health Llc Presbyopia treatment by lens alteration
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US9044439B2 (en) 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
WO2009111635A2 (en) 2008-03-05 2009-09-11 Encore Health, Llc Dithiol compounds, derivatives, and uses therefor
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
BRPI1008602A8 (pt) * 2009-02-18 2018-01-02 Eyeon Particle Sciences Llc uso de co-polímero bi-funcional para as aplicações oftálmicas e outras aplicações tópicas e locais
DK2442647T3 (en) 2009-06-15 2016-05-30 Encore Health Llc Dithiolforbindelser, derivatives thereof, and the uses of these
PL2442645T3 (pl) * 2009-06-15 2015-02-27 Encore Health Llc Estry choliny
JP2013524275A (ja) 2010-04-03 2013-06-17 ドシ，プラフル 薬剤を含む医療機器、その製造方法とその使用方法
US10413506B2 (en) 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
CA2833596A1 (en) * 2011-04-22 2012-10-26 Alcon Research, Ltd. Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
KR102310775B1 (ko) 2012-05-03 2021-10-07 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
CA2941518A1 (en) 2014-03-03 2015-09-11 Encore Vision, Inc. Lipoic acid choline ester compositions and methods of use
KR102218883B1 (ko) 2014-08-11 2021-02-23 보드 오브 슈퍼바이저스 오브 루이지애나 스테이트 유니버시티 앤드 애그리컬춰럴 앤드 메카니컬 컬리지 쓰루 더 엘에스유 에이쥐센터 생물활성, 나노입자포집된 항산화제의 전달
WO2018009177A1 (en) * 2016-07-06 2018-01-11 Eyeon Particle Sciences Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
ES2962154T3 (es) * 2018-05-29 2024-03-15 Jinno Inst Composición tópica
CN115919754B (zh) * 2023-01-06 2023-09-12 广州家安化妆品有限公司 一种用于灭活病毒的粘膜消毒凝胶及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703777A (en) 1950-05-02 1955-03-08 Iso Sol Company Inc Ophthalmological preparations and vehicles and method of making the same
US3549747A (en) 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
US3856919A (en) 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3947573A (en) 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3767788A (en) 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
US3767789A (en) 1971-06-21 1973-10-23 Burton Parsons & Co Inc Method of providing a synthetic mucus in vivo
US3987163A (en) 1973-07-27 1976-10-19 Burton, Parsons And Company, Inc. Polystyrene sulfonate containing opthalmic solutions
US3907985A (en) 1973-07-27 1975-09-23 Burton Parsons And Company Inc Polystyrene sulfonate containing opthalmic solutions
US4029817A (en) 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US4120949A (en) 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
GB2203039B (en) 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5141665A (en) 1987-03-31 1992-08-25 Sherman Laboratories, Inc. Cleaning, conditioning, storing and wetting system and method for rigid gas permeable contact lenses and other contact lenses
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US5457093A (en) 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
US5405878A (en) * 1993-06-18 1995-04-11 Wilmington Partners L.P. Contact lens solution containing cationic glycoside
CA2125060C (en) 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5585108A (en) 1994-12-30 1996-12-17 Nanosystems L.L.C. Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
US20020114778A1 (en) 2002-08-22
DE60126321D1 (de) 2007-03-15
KR100840438B1 (ko) 2008-06-20
US6703039B2 (en) 2004-03-09
BR0116186A (pt) 2003-12-16
CA2430995A1 (en) 2002-06-13
CN100350976C (zh) 2007-11-28
EP1339386B1 (en) 2007-01-24
JP2004514731A (ja) 2004-05-20
DE60126321T2 (de) 2007-06-21
HK1059728A1 (en) 2004-07-16
AU2002233978B2 (en) 2006-05-18
AU3397802A (en) 2002-06-18
WO2002045683A3 (en) 2003-01-16
CA2430995C (en) 2008-10-14
EP1339386A2 (en) 2003-09-03
ES2278799T3 (es) 2007-08-16
KR20030060977A (ko) 2003-07-16
WO2002045683A2 (en) 2002-06-13
CN1479631A (zh) 2004-03-03

Similar Documents

Publication Publication Date Title
MXPA03005044A (es) Sistema gelificante reversible para administracion ocular de farmacos.
HK1048428A1 (en) Ophthalmic drug delivery device.
HK1048427A1 (en) Drug delivery device.
ZA200107123B (en) Oral drug delivery system.
AU2123200A (en) Drug delivery device
MXPA03009727A (es) SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.
AU4985600A (en) Drug delivery device
AU2001264887A1 (en) Drug delivery device
HK1049438A1 (en) Sub-tenon drug delivery.
AU7333601A (en) Drug delivery management system
HUP0401438A3 (en) Drug delivery system
AU2463701A (en) Drug delivery system exhibiting permeability control
HUP0500795A2 (en) Gastric retention controlled drug delivery system
AU6938600A (en) Cervical agent delivery system
IL155272A0 (en) Systems for optimized drug delivery
AU2001273376A1 (en) Drug delivery device for animals
AU4947100A (en) Drug delivery device
HK1077523A1 (en) Proliposomal drug delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
ZA200401217B (en) Zero order controlled drug delivery system.
IL139177A0 (en) Sustained release drug delivery system
ZA200409726B (en) Monocompartment osmotic controlled drug delivery system.
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU2001244854A1 (en) Local drug delivery

Legal Events

Date Code Title Description
FG Grant or registration